Epclusa, Filmtabletten - 28 Swissmedic Key 66095001 Registration Holder Gilead Sciences Switzerland Sàrl Name Epclusa, Filmtabletten Date of registration 22.09.2016 Introduction of Sequence 22.09.2016 ATC-Classification Sofosbuvir and Velpatasvir (J05AP55) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.03. Show package size 28 Index Therapeuticus (Swissmedic) 08.03. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 9825.75 Limitation Yes Limitation text
Deductible 10 % Consumer price 10389.00 Feedback FB GTIN 7680660950018 Medication Code Synthetika Pharmacode 6823441 Disponibility
Composition sofosbuvirum 400 mg, velpatasvirum 100 mg, copovidonum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 2.85 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Sofosbuvirum 400 mg Velpatasvirum 100 mg
BAG: Active Agent Dose Sofosbuvirum 400 mg Velpatasvirum 100 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum Copovidonum E 171 color. E 172 color. Macrogol 3350 Magnesii Stearas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 03.02.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
